American Journal of Cardiology
Volume 100, Issue 6 , Pages 962-964, 15 September 2007

Examination of the Microcirculation Damage in Smokers Versus Nonsmokers With Vasospastic Angina Pectoris

  • Takashi Ashikaga, MD

      Affiliations

    • Department of Cardiology, Yokohama Minami Kyosai Hospital, Yokohama, Japan
    • Corresponding Author InformationCorresponding author: Tel: 81-45-782-2101; fax: 81-45-701-9159.
  • ,
  • Mitsuhiro Nishizaki, MD

      Affiliations

    • Department of Cardiology, Yokohama Minami Kyosai Hospital, Yokohama, Japan
  • ,
  • Hiroyuki Fujii, MD

      Affiliations

    • Department of Cardiology, Yokohama Minami Kyosai Hospital, Yokohama, Japan
  • ,
  • Saori Niki, MD

      Affiliations

    • Department of Cardiology, Yokohama Minami Kyosai Hospital, Yokohama, Japan
  • ,
  • Shingo Maeda, MD

      Affiliations

    • Department of Cardiology, Yokohama Minami Kyosai Hospital, Yokohama, Japan
  • ,
  • Noriyoshi Yamawake, MD

      Affiliations

    • Department of Cardiology, Yokohama Minami Kyosai Hospital, Yokohama, Japan
  • ,
  • Yukio Kishi, MD

      Affiliations

    • Department of Preventive Medicine, Tokyo Kyosai Hospital, Tokyo, Japan
  • ,
  • Mitsuaki Isobe, MD

      Affiliations

    • Department of Cardiology, Tokyo Medical and Dental University, Tokyo, Japan.

Endothelial dysfunction is considered one of the mechanisms underlying vasospastic angina pectoris (VSA). It is also known that smokers have abnormalities in endothelial dysfunction. Although smoking is a major risk factor for coronary artery disease, microvascular abnormalities have not been well shown. We investigated clinical characteristics and coronary reactivity with adenosine triphosphate in smokers with VSA. Twenty-two consecutive patients whose coronary spasm was documented in the left anterior descending (LAD) coronary artery with acetylcholine were enrolled. Coronary blood flow responses were also evaluated by intracoronary Doppler flow velocity recordings in the LAD coronary artery. Average peak velocities (APVs) were measured at baseline and intracoronary administration of adenosine triphosphate (50 μg) in 11 smokers (age 60 ± 9 years; 8 men) and 11 nonsmokers (age 61 ± 10 years, 5 men). Coronary flow reserve (CFR) was calculated by the ratio of baseline to hyperemic APV. Multivessel spasm was demonstrated in 6 smokers and only 2 nonsmokers (p <0.05). APV at rest in smokers (13.4 ± 3.0 cm/s) was similar to that in nonsmokers (13.5 ± 2.9 cm/s). However, CFR in smokers (2.6 ± 0.7) was significantly lower than in nonsmokers (3.4 ± 0.8; p <0.05). In conclusion, multivessel spasm was demonstrated in smokers in clinical settings, and microcirculation damage is prominent in smokers with VSA.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-9149(07)01135-6

doi:10.1016/j.amjcard.2007.04.035

American Journal of Cardiology
Volume 100, Issue 6 , Pages 962-964, 15 September 2007